Icon

VYTORIN (nda021687)- (10MG;10MG,10MG;20MG,10MG;40MG,10MG;80MG)

EZETIMIBE; SIMVASTATIN ORGANON
10MG;10MG,10MG;20MG,10MG;40MG,10MG;80MG
Yes No
2024-Jun-11 Expired
None None
None No
VYTORIN, which contains a cholesterol absorption inhibitor and an HMG-CoA reductase inhibitor (statin), is indicated as adjunctive therapy to diet to: • reduce elevated total-C, LDL-C, Apo B, TG, and non-HDL-C, and to increase HDL-C in patients with primary (heterozygous familial and non-familial) hyperlipidemia or mixed hyperlipidemia. • reduce elevated total-C and LDL-C in patients with homozygous familial hypercholesterolemia (HoFH), as an adjunct to other lipid-lowering treatments.
6 0 6
Total Other Developers 2
Drugs with Suitability No
10MG;10MG ** ** - - 5
10MG;20MG ** ** - 5 -
10MG;40MG ** ** Up - 5
10MG;80MG ** ** - - 5
NDA Sales Available Total Generic Sales Available
Yes 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** **** ** **. *****'* ************ *********, *** *********** **** **** ******, **********, ********* (**) *****, ****** ****** (***) ***
****** ****** **** *** ****** ****** ******* ******* *********** **** **. **-*-*, ***** ** ***** ********** ******, *****, ********, *** ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** **. *, *****-*, ****** **** *** *********, ****, ****** ******* ******, ***** (***) ***
****** ****** ****** ** ****** *************** ** *** ****, *** *********** ** ********** **, **********, *** **** (**) *****-****, ****** ****** (***) ***
****** ****** ****** ** ****** *************** ******* ******* *********** **** ** ** & **, ******* ******* ******** **** *******-***** *.*. **. **, ***.: ******, ***.: ******, *********, ** ******, ***** (***) ***
****** ***** **** *** ***** ************ ******* *********** ****** ** ****, ****, ****, **** ******* *****, ****** ********, *****, ******** ******* ******, ***** (***) ***
****** ********* ****** *** ****** ******* *** *********** ******* ******** ****, **** **. *, *, * & *, ***** **, ***********-****** **** ****, *********** ****, *********, ********* ******, ***** (***) ***
****** ********* ****** *** **** *** ***** ******* ***. *** *********** **** **. *-*, *-*/*, *-*/* ****** ********** ****, ****** ****, ********, ****** (***** ****** ******, ***** (***) ***
****** ********* ****** *** *** ********** ******* *********** ****-**, **** **.**, *****, *.*.***, ******** *******, ********* ******, ******** ********, ********, ****** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.